$康寶萊(HLF.US)$ NEWS Herbalife Reports Year-Over-Year Net Sales Growth for Second Consecutive Quarter; Raises Full-Year 2024 Adjusted EBITDA¹ Guidance Herbalife achieved year-over-year net sales growth for the second quarter in a row, with net sales of $1.3 billion, up 1.0% from 1Q '23. The company exceeded adjusted EBITDA guidance, reporting $138.3 million in adjusted EBITDA for the first quarter. Herbalife announced a new restructuring plan to streamline organizational structure, targeting...
$康寶萊(HLF.US)$ NEWS Herbalife Activates on Mexican Olympic Committee Partnership with Nutrition and Conditioning Training at Proactive Sports in Westlake Village
$康寶萊(HLF.US)$ Another NEWS Herbalife (NYSE: HLF) announces a $1.2 billion secured refinancing, including a $400 million Term Loan B facility and a $400 million revolving credit facility. The company aims to repay existing loans and notes, focusing on growth and shareholder value.
$康寶萊(HLF.US)$ NEWS Herbalife (HLF) announces the upsizing and pricing of $800 million senior secured notes due 2029, with a fixed annual interest rate of 12.25%. The company plans to use the proceeds to repay debt and for general corporate purposes.
S&P Global Ratings warns of potential further downgrades if Herbalife fails to raise sufficient debt capital to address its maturities through 2025. Uncertainty in the company's ability to refinance could negatively impact its credit rating and financial stability.
Investors expect Herbalife's poor earnings performance to persist, reflected in its low P/E ratio. Despite a promising earnings outlook, potential risks seem to be exerting significant pressure on the P/E ratio, indicating anticipated future earnings volatility.
Despite disappointing earnings, analysts' sentiment for Herbalife remains 'Moderate Buy'. B. Riley cut its price target on HLF to $16, indicating a potential 82% premium. Mean target price is $14, suggesting a 60% upside potential.
Analysts are more bearish after recent results, with a significant cut to EPS estimates. They expect Herbalife's revenue growth to slow down substantially, with revenues to the end of 2024 expected to display 0.5% growth annually, compared to a historical growth rate of 1.3% over the past five years. The analysts also cut their price targets, indicating increased pessimism about the business's intrinsic value.
The ~62% plunge in the stock over the past year is mainly due to poor financial results. SA Quant system rates the stock as 'Sell', pointing to slowing momentum and negative EPS revisions compared to other Consumer Staples stocks. SA analysts are neutral, while Wall Street is more bullish with a Buy rating.
康寶萊股票討論區
NEWS
Herbalife Reports Year-Over-Year Net Sales Growth for Second Consecutive Quarter; Raises Full-Year 2024 Adjusted EBITDA¹ Guidance
Herbalife achieved year-over-year net sales growth for the second quarter in a row, with net sales of $1.3 billion, up 1.0% from 1Q '23.
The company exceeded adjusted EBITDA guidance, reporting $138.3 million in adjusted EBITDA for the first quarter.
Herbalife announced a new restructuring plan to streamline organizational structure, targeting...
NEWS
Herbalife Activates on Mexican Olympic Committee Partnership with Nutrition and Conditioning Training at Proactive Sports in Westlake Village
Another NEWS
Herbalife (NYSE: HLF) announces a $1.2 billion secured refinancing, including a $400 million Term Loan B facility and a $400 million revolving credit facility. The company aims to repay existing loans and notes, focusing on growth and shareholder value.
NEWS
Herbalife (HLF) announces the upsizing and pricing of $800 million senior secured notes due 2029, with a fixed annual interest rate of 12.25%. The company plans to use the proceeds to repay debt and for general corporate purposes.
暫無評論